C. M. Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
C. M. Zhao has a total of 2 co-authors. Here are the top co-authors by number of shared publications:
- Guo-Gui Sun
Department of Chemoradiotherapy, Tangshan People's Hospital, NO. 65, Shengli Road, Lunan District, Tangshan, 063000, Hebei province, China,
1 shared publication S. H. Sheng
Department of Breast Surgery, Tangshan Workers Hospital, Tangshan, 063000, China
1 shared publication
Latest Publications
- 24 November 2013
- Published by Springer Nature in Tumor Biology
- Vol. 35 (4) , 3317-3326
BTG1 expression correlates with the pathogenesis and progression of breast carcinomas
This study aimed to analyze the expression, clinical significance of B cell translocation gene 1 (BTG1) in breast carcinoma and the biological effect in its cell line by BTG1 overexpression. Immunohistochemistry and western blot were used to analyze BTG1 protein expression in 72 cases of breast cancer and 36 cases of normal tissues to study the relationship between BTG1 expression and clinical factors. Recombinant lentiviral vector was constructed to over-express EMP-1 and then infect breast cancer MCF-7 cell line. Quantitative real-time RT-PCR (qRT-PCR) and western blot were used to detect the mRNA level and protein of BTG1. MTT assay, cell apoptosis, cell cycles, migration and invasion assays were also conducted as to the influence of the upregulated expression of BTG1 that might be found on MCF-7 cells biological effect. The level of BTG1 protein expression was found to be significantly lower in breast cancer tissue than normal tissues (P P P MMP-9 protein expression compared with MCF-7 cell untransfected BTG1 (P MMP-9 protein expression, suggesting that BTG1 may play important roles as a negative regulator to breast cancer cell.
- 24 November 2013
- Published by Springer Nature in Tumor Biology
- Vol. 35 (4) , 3317-3326
BTG1 expression correlates with the pathogenesis and progression of breast carcinomas
This study aimed to analyze the expression, clinical significance of B cell translocation gene 1 (BTG1) in breast carcinoma and the biological effect in its cell line by BTG1 overexpression. Immunohistochemistry and western blot were used to analyze BTG1 protein expression in 72 cases of breast cancer and 36 cases of normal tissues to study the relationship between BTG1 expression and clinical factors. Recombinant lentiviral vector was constructed to over-express EMP-1 and then infect breast cancer MCF-7 cell line. Quantitative real-time RT-PCR (qRT-PCR) and western blot were used to detect the mRNA level and protein of BTG1. MTT assay, cell apoptosis, cell cycles, migration and invasion assays were also conducted as to the influence of the upregulated expression of BTG1 that might be found on MCF-7 cells biological effect. The level of BTG1 protein expression was found to be significantly lower in breast cancer tissue than normal tissues (P P P MMP-9 protein expression compared with MCF-7 cell untransfected BTG1 (P MMP-9 protein expression, suggesting that BTG1 may play important roles as a negative regulator to breast cancer cell.